Tag Archives: cell-derived exosome therapeutic platform

from Proactive Investors by Giles Gwinnett Stem cell specialist ReNeuron (LON:RENE) says it’s upbeat after what it called a ‘transformational’ year, as it posted results for the year to end March. A share placing in July raised £25.3mln bolstering the ...

Read More »